Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;106(11):995-8.
doi: 10.1007/s00347-008-1898-5.

[Limbal stem cell deficiency after chemical burns : investigations on the epithelial phenotype and inflammation status]

[Article in German]
Affiliations

[Limbal stem cell deficiency after chemical burns : investigations on the epithelial phenotype and inflammation status]

[Article in German]
M Pauklin et al. Ophthalmologe. 2009 Nov.

Abstract

Limbal stem cell deficiency (LSCD) is clinically characterized by growth of fibrovascular pannus onto the corneal surface, chronic inflammation and impaired visual acuity. The aim of this study was to characterize the pannus tissue. Total RNA was isolated from six pannus samples and protein from three pannus samples from patients with LSCD caused by chemical burns. Normal human corneal tissue (n=6) and conjunctiva (n=6) were used as control tissues. The expression of the epithelial lineage markers keratin 3 (K3), K19 and MUC5AC, the inflammatory markers IL-1beta, ICAM-1 and VEGF was analyzed by Western Blotting and/or real-time PCR. Normal corneal tissue had a higher expression of K3 and a lower expression of K19 and MUC5AC in comparison to normal conjunctiva. A higher expression of inflammatory markers was seen in conjunctiva compared to corneal tissue. The pannus tissue showed a similar expression of lineage markers to conjunctiva but a higher expression of most inflammatory markers as compared to both control tissues. The analyzed samples of pannus in LSCD resembled conjunctiva and not cornea and showed a high expression of inflammatory markers indicating chronic inflammation.

PubMed Disclaimer

References

    1. Arch Ophthalmol. 2007 Oct;125(10):1337-44 - PubMed
    1. Invest Ophthalmol Vis Sci. 1993 Jul;34(8):2449-59 - PubMed
    1. Curr Opin Ophthalmol. 2001 Aug;12(4):242-9 - PubMed
    1. J Cell Biol. 1986 Jul;103(1):49-62 - PubMed
    1. Cornea. 1996 Nov;15(6):549-56 - PubMed

Publication types

LinkOut - more resources